Tesofensine: Dosage, Protocol, and Research Guide
Triple monoamine reuptake inhibitor for weight loss
Mechanism
Inhibits reuptake of serotonin, norepinephrine, and dopamine, reducing appetite and increasing metabolism
Protocol at a glance
| Starting dose | 0.25mg |
|---|---|
| Maintenance dose | 0.5mg |
| Maximum dose | 1mg |
| Frequency | Daily |
| Typical duration | 12-24 weeks |
| Route | Oral |
| Injection site | N/A |
| Timing | Morning |
Side effects
- Dry mouth
- Insomnia
- Constipation
- Increased heart rate
Contraindications
- Cardiovascular disease
- Uncontrolled hypertension
- MAO inhibitor use
Protocol notes
- Potent appetite suppressant
- Monitor blood pressure
- May cause mood elevation
- Significant weight loss potential
- Not yet FDA approved
Frequently asked questions
What is Tesofensine and how does it work?
Tesofensine is a triple monoamine reuptake inhibitor that enhances the activity of serotonin, norepinephrine, and dopamine in the central nervous system. By preventing these neurotransmitters from being reabsorbed, Tesofensine maintains elevated levels at synaptic junctions. This mechanism triggers appetite suppression through serotonin activity, reduces hunger signals via dopamine, and increases metabolic rate through norepinephrine elevation. The multi-targeted approach makes Tesofensine particularly effective for weight loss compared to single-pathway compounds.
How do you dose Tesofensine?
Tesofensine dosing follows a progressive protocol: start with 0.25mg daily in the morning, titrate to a 0.5mg maintenance dose, and may increase to a maximum of 1mg daily. This oral compound is taken once daily, with treatment duration typically spanning 12 to 24 weeks in research protocols. Begin at the lowest dose to assess individual tolerance before advancing. Always adjust dosing under appropriate medical supervision.
What are the main side effects of Tesofensine?
Documented side effects include dry mouth, insomnia, constipation, and increased heart rate. Most are mild to moderate and manageable through practical adjustments: morning administration minimizes sleep disruption, increased hydration addresses dry mouth, and dietary fiber helps with constipation. More serious potential effects include mood elevation and cardiovascular stimulation. Blood pressure monitoring is essential during use. Any persistent or severe side effects warrant discontinuation and medical consultation.
Who should avoid Tesofensine?
Tesofensine is contraindicated for individuals with cardiovascular disease, uncontrolled hypertension, or those taking monoamine oxidase (MAO) inhibitors. The combination of Tesofensine with MAO inhibitors poses significant safety risks. Anyone with a history of heart conditions or elevated blood pressure must consult a licensed physician before any consideration of use. Comprehensive medical screening is essential prior to exploring this compound.
Is Tesofensine FDA approved?
No. Tesofensine is not FDA-approved for human use and remains an experimental compound under research investigation. For research purposes only — not FDA-approved for human use. Consult a licensed physician before use. This distinction is critical: Tesofensine has not completed the regulatory approval process required for standard pharmaceutical use and exists solely within the research domain. All exploration must occur under appropriate medical supervision.
What weight loss results can I expect from Tesofensine?
Research indicates Tesofensine has significant weight loss potential through its appetite-suppressing and metabolism-enhancing mechanisms. However, individual results vary based on baseline weight, caloric adherence, exercise activity, and metabolic rate. Published research documents its efficacy as a potent weight loss medicine, but comparative outcome data remains limited. All users should maintain realistic expectations and work with a healthcare provider to establish measurable goals.
How long should you take Tesofensine?
Standard research protocols use Tesofensine for 12 to 24 weeks, providing an adequate intervention window to evaluate effects on body composition and metabolic parameters. This timeframe allows sufficient assessment while limiting prolonged monoamine system stimulation. Individual duration may vary based on response and tolerance. Discontinuation should occur under medical guidance, with continued cardiovascular monitoring recommended through and potentially beyond the treatment period.
What monitoring is needed during Tesofensine use?
Blood pressure monitoring is essential due to potential cardiovascular effects and increased heart rate. Regular assessment of mood, appetite suppression, and side effect tolerance is important. Maintain detailed records of body weight, energy levels, sleep quality, and mood changes. Baseline cardiovascular assessment before starting and periodic re-assessment throughout the 12-24 week protocol are strongly recommended. All monitoring should occur under appropriate medical supervision.
More GLP-1 & Weight Loss peptides · All peptide guides · Free dose calculator
Educational reference only — not medical advice. Work with a qualified clinician.